Technology | March 29, 2012

St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement


March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire. FFR measurement identifies the severity of narrowings in the coronary arteries and allows for a more effective assessment of coronary lesions, or blockages, resulting in more accurate diagnosis and improved appropriate treatment of coronary artery blockages.

The PressureWire with Agile Tip was designed to replicate the performance of standard percutaneous coronary intervention (PCI) guidewires and delivers exceptional handling even in the most challenging anatomies. Available in both of the company’s Aeris (wireless) and Certus PressureWire models, this eighth-generation guidewire also can deliver interventional tools more easily for faster and more cost-effective PCI.

Another new feature in the next-generation PressureWire is a proprietary hydrophilic coating that reduces friction within guide catheters and stent delivery catheters, allowing for easier deployment of stents and coronary balloons.

“In the evolution of our PressureWire family, we have long sought to match or exceed the handling performance of conventional workhorse PCI guidewires, a significant challenge owing to the presence of the pressure sensor and signal cables,” said Frank Callaghan, president of the St. Jude Medical Cardiovascular Division. “Based on the clinical feedback obtained to date, this eighth generation family of guidewires gives us confidence we have risen to the challenge.”

When integrated into routine lab procedures, measuring FFR, as shown by the FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) study sponsored by St. Jude Medical, reduces the risk of death or heart attack by 34 percent. PressureWire technology from St. Jude Medical was used exclusively in the FAME and FAME II trials and has been proven in more than 500 additional studies. Using PressureWire Aeris or PressureWire Certus to measure FFR helps ensure access to accurate information in the cath lab, increasing the efficiency and efficacy of coronary revascularization.

For more information: www.sjm.com


Related Content

News | FFR Technologies

Oct. 27, 2024 — HeartFlow, Inc. recently announced seven-year data confirming the use of HeartFlow’s AI-enabled ...

Home October 30, 2024
Home
News | FFR Technologies

June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy ...

Home June 04, 2024
Home
News | FFR Technologies

May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced ...

Home May 23, 2024
Home
News | FFR Technologies

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...

Home January 03, 2024
Home
News | FFR Technologies

June 28, 2023 — CathWorks announced that the first patient has been enrolled in the Advancing Cath Lab Results with ...

Home June 28, 2023
Home
News | FFR Technologies

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

Home March 03, 2023
Home
News | FFR Technologies

January 4, 2022 - Pie Medical Imaging (PMI), a global leader in cardiac imaging, part of the Esaote Group, recently ...

Home January 04, 2022
Home
News | FFR Technologies

December 13, 2021 - HeartFlow Inc., the leader in revolutionizing precision heart care, today announced it has submitted ...

Home December 13, 2021
Home
News | FFR Technologies

November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...

Home November 09, 2021
Home
News | FFR Technologies

November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...

Home November 09, 2021
Home
Subscribe Now